The concept of axial spondyloarthritis: Joint statement of the spondyloarthritis research and treatment network and the assessment of spondyloarthritis international society in response to the US food and drug administration's comments and concerns

Arthritis and Rheumatology

Volumn 66, Issue 10, 2014, Pages 2649-2656

  Deodhar, Atul ^a   Reveille, John D ^b   Van Den Bosch, Filip ^c   Braun, Jürgen ^d   Burgos Vargas, Ruben ^e   Caplan, Liron ^f   Clegg, Daniel O ^g   Colbert, Robert A ^h   Gensler, Lianne S ⁱ   Van Der Heijde, Désirée ^j,k   Van Der Horst Bruinsma, Irene E ^l   Inman, Robert D ^m   Maksymowych, Walter P ⁿ   Mease, Philip J ^o   Raychaudhuri, Siba ^p   Reimold, Andreas ^q   Rudwaleit, Martin ^r   Sieper, Joachim ^r   Weisman, Michael H ^s   Landewé, Robert B M ^t  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d RHEUMAZENTRUM RUHRGEBIET   (Germany)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^h NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k DIAKONHJEMMET HOSPITAL   (Norway)

^l VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

^o Seattle Rhumatology Associates   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^r CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^s CEDARS SINAI MEDICAL CENTER   (United States)

^t ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADVISORY COMMITTEE; ARTICLE; AXIAL SPONDYLOARTHRITIS; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; FOOD AND DRUG ADMINISTRATION; HUMAN; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; SACROILIAC JOINT; SPONDYLARTHRITIS; TREATMENT INDICATION; UNITED STATES;

HUMANS; SPONDYLARTHRITIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84908388839     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38776     Document Type: Article

References (24)

1. Davis JC Jr, van der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, et al, for the Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 2003; 48: 3230-6.
2. Rudwaleit M, Landewe R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis. Part I. Classification of paper patients by expert opinion including uncertainty appraisal [published erratum appears in Ann Rheum Dis 2011;70:1519]. Ann Rheum Dis 2009; 68: 770-6.
3. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25-31.
4. National Health and Nutrition Examination Survey 2009-2010. Inflammatory arthritis questionnaire. URL: http://www.cdc.gov/nchs/data/nhanes/nhanes-09-10/arq-f.pdf.
5. Reveille JD, Witter JP, Weisman MH,. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken) 2012; 64: 905-10.
6. Haroon N, Inman RD,. Endoplasmic reticulum aminopeptidases: biology and pathogenic potential. Nat Rev Rheumatol 2010; 6: 461-7.
7. Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial [published erratum appears in Lancet 2014;383:1548]. Lancet 2013; 382: 1705-13.
8. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
9. Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis. Part II. Validation and final selection. Ann Rheum Dis 2009; 68: 777-83.
10. Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (Hoboken) 2012; 64: 1415-22.
11. Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 2013; 72: 815-22.
12. Landewe R, Braun J, Deodhar A, Dougados M, Maksymowych WP, Mease PJ, et al. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomized placebo-controlled Phase 3 study. Ann Rheum Dis 2014; 73: 39-47.
13. Yim S,. Axial spondyloarthritis: regulatory considerations on its use as an indication for drug development. FDA Arthritis Advisory Committee Meeting July 22, 2013: intorductory remarks. URL: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/arthritisadvisorycommittee/ucm366488.pdf.
14. Van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, et al, and the Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005; 52: 582-91.
15. Inman RD, Davis JC Jr, van der Heijde D, Diekman L, Sieper J, Kim SI, et al. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 2008; 58: 3402-12.
16. Baraliakos X, Haibel H, Listing J, Sieper J, Braun J,. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 2014; 73: 710-5.
17. Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013; 65: 2645-54.
18. Weber U, Lambert RG, Ostergaard M, Hodler J, Pedersen SJ, Maksymowych WP,. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum 2010; 62: 3048-58.
19. Collantes E, Veroz R, Escudero A, Munoz E, Munoz MC, Cisnal A, et al, the Spanish Spondyloarthropathy Study Group. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spondyloarthropathies. Joint Bone Spine 2000; 67: 516-20.
20. Sampaio-Barros PD, Bortoluzzo AB, Conde RA, Costallat LT, Samara AM, Bertolo MB,. Undifferentiated spondyloarthritis: a longterm follow up. J Rheumatol 2010; 37: 1195-9.
21. Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM,. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis international Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (Hoboken) 2013; 65: 1299-306.
22. Raychaudhuri S, Deodhar A,. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 2014; 48-9: 128-33.
23. Van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewe R, et al, for the Assessment of SpondyloArthritis international Society. 2010 update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 2011; 70: 905-8.
24. Van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van Gaalen F, Reijnierse M, et al. ASAS modification of Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis 2013; 72: 1646-53.